ArticleFrontiers in pharmacology2019
Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US.
Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences.Future oncology (London, England) · 2026Article
- What Next for the Science of Patient Preference? Interoperability, Standardization, and Transferability.The patient · 2025Review
- A genuine need or nice to have? Understanding HTA representatives' perspectives on the use of patient preference data.International journal of technology assessment in health care · 2024Article
- Different diseases, different needs: Patient preferences for gene therapy in lysosomal storage disorders, a probabilistic threshold technique survey.Orphanet journal of rare diseases · 2024Article
- What are the Unmet Needs and Most Relevant Treatment Outcomes According to Patients with Inflammatory Bowel Disease? A Qualitative Patient Preference Study.Journal of Crohn's & colitis · 2023Review
- Article
- How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action.Frontiers in pharmacology · 2023Article
- Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique survey.Haemophilia : the official journal of the World Federation of Hemophilia · 2021Article
- Use of Patient Preferences in Health Technology Assessment: Perspectives of Canadian, Belgian and German HTA Representatives.The patient · 2021Article
- Taking into Account Patient Preferences: A Consensus Study on the Assessment of Psychological Dimensions Within Patient Preference Studies.Patient preference and adherence · 2021Article
- Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study.Frontiers in medicine · 2021Article
- Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and Italy.Frontiers in pharmacology · 2021Article
- Can We Afford to Exclude Patients Throughout Health Technology Assessment?Frontiers in medical technology · 2021Article
- Patient Centricity in Patient Preference Studies: The Patient Perspective.Frontiers in medicine · 2020Article
- Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study.Frontiers in pharmacology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.